Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), PAK1 inhibitors(PAK protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CN | 01 Nov 2023 |